NCT06454162

Brief Summary

this study will be conducted to investigate the effect of adding Modified Ketogenic diet to exercise program in treating obese patient with multiple sclerosis.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
64

participants targeted

Target at P50-P75 for not_applicable multiple-sclerosis

Timeline
Completed

Started Jun 2024

Shorter than P25 for not_applicable multiple-sclerosis

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 6, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 12, 2024

Completed
3 days until next milestone

Study Start

First participant enrolled

June 15, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

June 12, 2024

Status Verified

June 1, 2024

Enrollment Period

7 months

First QC Date

June 6, 2024

Last Update Submit

June 6, 2024

Conditions

Keywords

Modified Ketogenic DietMultiple Sclerosis

Outcome Measures

Primary Outcomes (1)

  • VO2 max

    VO2 max will be measured by cardiopulmonary exercise testing. Maximum level of oxygen consumption definite indicator of muscular work capacity Normal Range = 1,700 - 5,800 ml / min

    up to three months

Secondary Outcomes (8)

  • exercise capacity

    up to three months

  • fatigue

    up to three months

  • life disability

    up to three months

  • Oxygen Consumption

    up to three months

  • Carbon Dioxide Production

    up to three months

  • +3 more secondary outcomes

Study Arms (2)

Modified Ketogenic Diet

EXPERIMENTAL

thirty-two patients will receive modified ketogenic diet and exercise program for three months

Other: Modified Ketogenic DietOther: exercise program

exercise program

ACTIVE COMPARATOR

thirty-two patients will receive an exercise program three times per week for three months

Other: exercise program

Interventions

the patients will receive KD after nutritional counseling, patients will instructed to start by limiting carbohydrate intake to just 20 g/day for 4 weeks in order to establish ketosis. Then, patients increase their carbohydrate intake by 5 g each week until they reach their individual maximum (approximately 40 g) to maintain stable ketosis. All carbohydrates relevant for elevating blood glucose are limited to 40-50 g/ day. In addition, the glycemic index and glycemic load of carbohydrates have to be below 50 and 60, respectively. This ketogenic diet is equivalent to a traditional ketogenic diet, but with a liberalized macronutrient composition of 70-80% fats, 15-20% proteins and 5-10% carbohydrates (compared to a traditional ketogenic diet with 90% fat, 6% proteins and 4% carbohydrates)+ exercise program

Modified Ketogenic Diet

the patients will receive exercise program in the form of aerobic training (10-30 minutes at moderate intensity) and resistance training (1-3 sets of 8-15 repetition maximum (RM)

Modified Ketogenic Dietexercise program

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Confirmed MS based on McDonald Criteria.
  • Patients had to be fully ambulatory, not requiring assistive devices.
  • The ages of 18 and 50
  • Patients Body mass index (BMI) less than 30 Kg/m2.

You may not qualify if:

  • Evidence of active disease or relapse phase within the last 30 days
  • Chronic heart failure, cancer, chronic kidney disease, infection with human Immunodeficiency
  • Addiction to drugs or alcohol.
  • Pregnancy and Diabetic patient.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Multiple Sclerosis

Interventions

Resistance Training

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
opaque sealed envelope
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Modified Ketogenic Diet and exercise program
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principle investigator nabil mahmoud ismail abdel-aal

Study Record Dates

First Submitted

June 6, 2024

First Posted

June 12, 2024

Study Start

June 15, 2024

Primary Completion

December 30, 2024

Study Completion

December 30, 2024

Last Updated

June 12, 2024

Record last verified: 2024-06